The purpose of this study is to evaluate whether zoledronic acid given once yearly for two years to men and women after surgical repair of a recent hip fracture will significantly reduce the rate of all re-occurring (new) osteoporotic fractures. All patients will receive vitamin D and calcium.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
2,127
Significant reduction in rate of clinical fractures after surgical repair of hip fracture
Increase in total hip and femoral neck BMDs
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Alabama Hospital
Birmingham, Alabama, United States
Osteoporosis Diagnostic Center
Eureka, California, United States
Sharp Grossmont Hosptial
La Mesa, California, United States
The Permanente Group
Santa Rosa, California, United States
Radiant Research Lake Worth
Lake Worth, Florida, United States
Atlanta Resarch Center
Decatur, Georgia, United States
United Osteoporosis Center Health Services
Gainesville, Georgia, United States
Galesburg Orthopedic Services LTD
Galesburg, Illinois, United States
Illinois Bone and Joint Institute
Morton Grove, Illinois, United States
Mercy Arthritis and Osteoporosis Center
Des Moines, Iowa, United States
...and 18 more locations